LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2017/1126 of 23 June 2017 amending Regulation (EC) No 903/2009 and Implementing Regulations (EU) No 373/2011, (EU) No 374/2013 and (EU) No 1108/2014 as regards the name of the EU representative of the holder of the authorisation of a preparation of Clostridium butyricum (FERM-BP 2789) (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/1126 of 23 June 2017 amending Regulation (EC) No 903/2009 and Implementing Regulations (EU) No 373/2011, (EU) No 374/2013 and (EU) No 1108/2014 as regards the name of the EU representative of the holder of the authorisation of a preparation of Clostridium butyricum (FERM-BP 2789) (Text with EEA relevance. )

Implementing Regulation (EU) 2017/1126 · Regulation · 6 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Amendment to Regulation (EC) No 903/2009

Article 1

Open ↗

Regulation (EC) No 903/2009 is amended as follows: (1) In the Title, the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Miyarisan Pharmaceutical Europe S.L.U’ are replaced by the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’. (2) In the Annex to Regulation (EC) No 903/2009, in the second column ‘Name of the holder of authorisation’, the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.’ are replaced by the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’.

Amendment to Implementing Regulation (EU) No 373/2011

Article 2

Open ↗

Implementing Regulation (EU) No 373/2011 is amended as follows: (1) In the Title, the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Miyarisan Pharmaceutical Europe S.L.U’ are replaced by the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’. (2) In the Annex to Implementing Regulation (EU) No 373/2011, in the second column, the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.’ are replaced by the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’.

Amendment to Implementing Regulation (EU) No 374/2013

Article 3

Open ↗

Implementing Regulation (EU) No 374/2013 is amended as follows: (1) In the Title, the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Miyarisan Pharmaceutical Europe S.L.U’ are replaced by the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’. (2) In the Annex to Implementing Regulation (EU) No 374/2013, in the second column, the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.’ are replaced by ‘Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’.

Amendment to Implementing Regulation (EU) No 1108/2014

Article 4

Open ↗

Implementing Regulation (EU) No 1108/2014 is amended as follows: (1) In the Title, the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd, represented by Miyarisan Pharmaceutical Europe S.L.U’ are replaced by the words ‘holder of authorisation Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’. (2) In the Annex to Implementing Regulation (EU) No 1108/2014, in the second column, the words ‘Miyarisan Pharmaceutical Co. Ltd represented by Miyarisan Pharmaceutical Europe S.L.U.’ are replaced by ‘Miyarisan Pharmaceutical Co. Ltd represented by Huvepharma NV Belgium’.

Transitional measures

Article 5

Open ↗

Existing stocks of the additive, premixtures and compound feed containing the additive, which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.

Entry into force

Article 6

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Other acts of the same type
Regulation (EU) 2026/1395 of the European Parliament and of the Council of 17 June 2026 on applying a generalised scheme of tariff preferences and repealing Regulation (EU) No 978/2012Commission Implementing Regulation (EU) 2026/1391 of 16 June 2026 on the approval of an amendment to the product specification of the traditional speciality guaranteed Moules de bouchotCommission Implementing Regulation (EU) 2026/1311 of 15 June 2026 amending Implementing Regulation (EU) 2025/807 as regards administrative and minor changes to the Union authorisation of the biocidal product C(M)IT/MIT & Glutaraldehyde FormulationsCommission Regulation (EU) 2026/1314 of 15 June 2026 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1,4-dimethylnaphthalene, chlormequat, metribuzin, metribuzin-desamino-diketo (metribuzin-DADK), terbuthylazine and triclopyr in or on certain productsCommission Implementing Regulation (EU) 2026/1315 of 15 June 2026 setting out the content and practical arrangements for the quality reports and metadata pursuant to Regulation (EU) 2025/941 of the European Parliament and of the CouncilCouncil Regulation (EU) 2026/1336 of 15 June 2026 amending Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Regulation (EU) 2026/1353 of 15 June 2026 amending Implementing Regulations (EU) 2020/617 and (EU) No 540/2011 as regards the conditions of approval of the active substance metalaxyl-MCouncil Implementing Regulation (EU) 2026/1356 of 15 June 2026 implementing Regulation (EU) 2024/2642 concerning restrictive measures in view of Russia’s destabilising activitiesCouncil Implementing Regulation (EU) 2026/1358 of 15 June 2026 implementing Regulation (EU) 2023/888 concerning restrictive measures in view of actions destabilising the Republic of MoldovaCouncil Implementing Regulation (EU) 2026/1361 of 15 June 2026 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Implementing Regulation (EU) 2026/1362 of 15 June 2026 implementing Regulation (EU) 2024/1485 concerning restrictive measures in view of the situation in RussiaCommission Implementing Regulation (EU) 2026/1280 of 12 June 2026 fixing the adjustment rate for direct payments pursuant to Regulation (EU) 2021/2116 of the European Parliament and of the Council in respect of the calendar year 2026

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next